For antibiotics, the right dose is restraint

India’s dependence on antibiotics as a convenient cure-all for routine illnesses has reached an inflection point. A global study published in The Lancet Public Health has highlighted a worrying imbalance in the country’s antibiotic use: An over-reliance on stronger medicines even as safer first-line medicines remain underused. The World Health Organisation classifies antibiotics into three categories — “access” drugs, which are recommended as first-line treatments for common infections; “watch” drugs, which are broader-spectrum medicines that should be reserved for specific situations; and “reserve” drugs, intended as a last line of defence against highly resistant infections. The study estimates India’s optimal antibiotic use at 9.9 to 14.7 defined daily doses per 1,000 people per day. Actual use, however, stands much higher at 18.3 doses, with “watch” antibiotics at 9.3 doses against a recommended 6 doses. “Access” antibiotics, at 4.5 doses, fall well short of what is needed.

The preference for “watch” drugs reveals the challenge in how antibiotics are understood, prescribed and consumed. A prescription for a broad-spectrum antibiotic can often feel like reassurance both to a patient seeking quick recovery and to a doctor working in an overstretched healthcare system. But each unnecessary dose narrows the options available for future infections. At the same time, the underuse of “reserve” antibiotics in genuinely resistant cases points to another systemic failure: Ensuring that the right medicine reaches the right patient at the right moment. Fragmented healthcare delivery, poor diagnostic access, and — beyond the clinic — the liberal use of antibiotics in livestock and agriculture, all feed India’s rising burden of antimicrobial resistance, where bacteria become resistant to common drugs and infections become more difficult and expensive to treat.

Given the country’s burden of infectious disease, antibiotics will remain indispensable. Addressing the problem must, thus, begin with replacing quick-fix prescriptions with evidence-based care. National Action Plan on Antimicrobial Resistance 2.0 (2025–2029) places antimicrobial stewardship at the heart of the response, seeking to curb inappropriate usage across human healthcare, animal husbandry and agriculture. A stricter and more coordinated compliance mechanism across the pharmaceutical supply chain is essential to curb indiscriminate over-the-counter sales and irrational fixed-dose combinations.

Overall Analysis

The editorial highlights India’s growing antibiotic misuse and warns that indiscriminate consumption is accelerating the threat of antimicrobial resistance (AMR). Using findings from a recent Lancet Public Health study, the author argues that the country is relying excessively on powerful antibiotics while neglecting safer first-line medicines. The central message is that the greatest medicine against antibiotic resistance is not stronger drugs, but greater restraint in their use.

The editorial opens with a sense of urgency by describing India’s antibiotic use as having reached an “inflection point,” signalling that the problem has become too serious to ignore. It introduces the World Health Organisation’s classification of antibiotics—Access, Watch, and Reserve—to explain that antibiotics should be used according to medical necessity rather than convenience. The statistical evidence from the Lancet study strengthens the editorial’s credibility, making the argument evidence-based rather than emotional.

The second part examines why stronger “Watch” antibiotics are overused. The author explains that patients often expect quick relief, while overburdened doctors may prescribe broad-spectrum antibiotics as an easier solution. This creates a dangerous cycle where unnecessary prescriptions reduce the future effectiveness of these medicines. The editorial also broadens the discussion beyond hospitals, pointing to weak diagnostic facilities, fragmented healthcare, over-the-counter drug sales, and excessive antibiotic use in livestock and agriculture. By connecting these multiple factors, the author demonstrates that antimicrobial resistance is not merely a medical issue but a systemic public health challenge involving healthcare, regulation, agriculture, and pharmaceutical practices.

In the final section, the editorial adopts a solution-oriented approach. Rather than advocating restrictions alone, it calls for evidence-based prescribing, stronger antimicrobial stewardship, and stricter regulation of antibiotic distribution. It welcomes the National Action Plan on Antimicrobial Resistance 2.0 (2025–2029) but emphasizes that policy success will depend on effective implementation, coordinated regulation, and responsible behaviour by doctors, pharmacists, farmers, and patients alike.

Overall, the editorial presents antimicrobial resistance as a silent but rapidly growing crisis. It argues that antibiotics must remain life-saving medicines, not routine cures for every illness, and that responsible use today is essential to preserve their effectiveness for future generations.

Important Vocabulary (5)

1. Inflection Point – A critical stage where a significant change begins to occur.
2. Indispensable – Absolutely necessary; cannot be replaced.
3. Antimicrobial Stewardship – The responsible and evidence-based use of antibiotics to prevent resistance.
4. Indiscriminate – Done without careful judgment or control.
5. Broad-spectrum – Effective against a wide variety of bacteria.

Conclusion & Tone

The editorial argues that India’s fight against antimicrobial resistance depends not on discovering more antibiotics but on using existing ones responsibly. It calls for scientific prescribing practices, stronger regulation, better diagnostics, and coordinated implementation of national policy to ensure that antibiotics remain effective for future generations.

Tone: Analytical, evidence-based, cautionary, and solution-oriented.